Testing the PEST hypothesis using relevant Rett mutations in MeCP2 E1 and E2 isoforms
Ladan Kalani,Bo-Hyun Kim,Alberto Ruiz de Chavez,Anastasia Roemer,Anna Mikhailov,Jonathan K Merritt,Katrina V Good,Robert L Chow,Kerry R Delaney,Michael J Hendzel,Zhaolan Zhou,Jeffrey L Neul,John B Vincent,Juan Ausió
DOI: https://doi.org/10.1093/hmg/ddae119
2024-11-05
Abstract:Mutations in methyl-CpG binding protein 2 (MeCP2), such as the T158M, P152R, R294X, and R306C mutations, are responsible for most Rett syndrome (RTT) cases. These mutations often result in altered protein expression that appears to correlate with changes in the nuclear size; however, the molecular details of these observations are poorly understood. Using a C2C12 cellular system expressing human MeCP2-E1 isoform as well as mouse models expressing these mutations, we show that T158M and P152R result in a decrease in MeCP2 protein, whereas R306C has a milder variation, and R294X resulted in an overall 2.5 to 3 fold increase. We also explored the potential involvement of the MeCP2 PEST domains in the proteasome-mediated regulation of MeCP2. Finally, we used the R294X mutant to gain further insight into the controversial competition between MeCP2 and histone H1 in the chromatin context. Interestingly, in R294X, MeCP2 E1 and E2 isoforms were differently affected, where the E1 isoform contributes to much of the overall protein increase observed, while E2 decreases by half. The modes of MeCP2 regulation, thus, appear to be differently regulated in the two isoforms.